glp 1 npo guidelines WHO Releases on GLP-1 Use for Obesity Treatment New Year, New Bod? Words

Evidence that many people may stop their use of obesity drugs not long after starting therapy casts doubt about the sustainability of weight loss to achieve long-term positive health outcomes

Alternatively, you can fill out our online contact form and we will get in touch with you for an appointment as soon as possible!

While more research is needed, the study suggests that there may be some risks in addition to benefits of using GLP-1s in people with breast cancer and obesity who are taking hormonal therapy

J.ThuretS.et al

The prevalence of diabetes mellitus type 2 in people with alcohol use disorders: a systematic review and large scale meta-analysis

Diabetes Ther (2021) 12(1):14357